JBF Capital’s Apellis Pharmaceuticals APLS Stock Holding History

JBF Capital’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-20,532	Closed	-$826K	–	103
2026 Q1	$826K	Buy	+20,532	New	+$442K	0.12%	54

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

JBF Capital's APLS Position: Q2 2026 in Review

JBF Capital sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 20,532 shares — an estimated $826K sold.

JBF Capital first reported a position in APLS in Q1 2026 and held it in 1 quarter. The position peaked at $826K in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

JBF Capital reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
JBF Capital sold 20,532 Apellis Pharmaceuticals shares in Q2 2026, an estimated $826K.
JBF Capital first reported a position in Apellis Pharmaceuticals in Q1 2026 and held it in 1 quarter.
JBF Capital's Apellis Pharmaceuticals position peaked at $826K in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on JBF Capital's 13F filing for Q2 2026, filed 13 Aug 2026.